Next Generation News and Research

RSS

Gene Codes releases Sequencher 5.0

Gene Codes Corporation announces the release of Sequencher 5.0. It incorporates new DNA sequence data alignment algorithms with SNP and methylation analysis for next-generation DNA sequence data. Performance for assembly and alignment of sequences and contigs is hundreds of times faster.

28 Jun 2011

EnVivo initiates EVP-0962 GSM Phase 1 clinical trial for Alzheimer’s disease

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it recently initiated a Phase 1 clinical trial of EVP-0962, its potent and selective gamma secretase modulator (GSM), in healthy volunteers.

27 Jun 2011

Transcatheter valve replacement safe and effective alternative to open-heart surgery

An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates for open heart valve replacement surgery.

27 Jun 2011

Obama visit highlights importance of U.S. engagement in Africa

First Lady Michelle Obama's trip to Africa this week "is focusing national attention on the serious U.S. strategic interests on the continent," Steve Morrison, director of the Global Health Policy Center at the Center for Strategic and International Studies, and Lisa Carty, deputy director of the CSIS center, write in a Politico opinion piece.

24 Jun 2011

Stresses can change gene expression without DNA sequence change

None of us are strangers to stress of various kinds. It turns out the effects of all those stresses can change the fate of future generation, influencing our very DNA without any change to the underlying sequence of As, Gs, Ts and Cs. Now, researchers reporting in the June 24th issue of Cell, a Cell Press publication, have new evidence that helps to explain just how these epigenetic changes really happen.

24 Jun 2011

RIKEN researchers reveal mechanism for stress-induced epigenetic change

Researchers at RIKEN have uncovered a mechanism by which the effects of stress in the fly species Drosophila are inherited epigenetically over many generations through changes to the structure of chromatin, the material that makes up the cell nucleus.

24 Jun 2011

FDA clears GE Healthcare's new mobile x-ray platform

GE Healthcare today announced FDA clearance of Optima XR220amx, Optima XR200amx and Brivo XR285amx - a new platform of user-friendly, mobile x-ray systems offering improvements from its predecessors in reliability, accessibility and flexibility to help address the increasingly specialized radiographic needs of patients.

24 Jun 2011

NEOLUX, CEA-Leti collaborate to develop, manufacture smart LED systems

CEA-Leti and NEOLUX announced a new partnership aimed at developing and manufacturing innovative LED modules and products for lighting.

23 Jun 2011

Ghanaian, Brazilian leaders awarded World Food Prize

"John Kufuor of Ghana and Luiz Inacio Lula da Silva of Brazil won the $250,000 World Food Prize for cutting hunger in half while serving as president of their nations, the prize organizers announced on Tuesday," Reuters reports.

23 Jun 2011

Sandia receives four R&D Magazine's 2011 awards

Sandia National Laboratories researchers - competing in an international pool of universities, corporations and government labs - captured three prestigious R&D 100 Awards in this year's contest, and were cowinners of a fourth.

23 Jun 2011

CPDC, UHN to advance use of medical isotopes for cancer treatment and diagnosis

CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.

23 Jun 2011

Sanofi Pasteur establishes new vaccine research and development facility in Canada

Mark Lievonen, President of Sanofi Pasteur Limited, and Premier Dalton McGuinty today opened a $101 million dollar vaccine research and development facility at Sanofi Pasteur's Connaught Campus in north Toronto. This new facility establishes the Connaught Campus as the North American Centre of Excellence in analytical and bioprocessing R&D for Sanofi Pasteur globally.

23 Jun 2011

NJIT research professor's work on sugar-based chemicals tops ACS must-read list

NJIT Research Professor Mike Jaffe's recent book chapter about sugar-based chemicals is topping the American Chemical Society (ACS) book series' must-read list.

22 Jun 2011

Boehringer Ingelheim, Ashoka to launch three-year global health initiative

Ashoka and Boehringer Ingelheim announced today that they will launch a three-year global initiative to improve health in communities around the world. The "Making More Health" initiative will promote healthy individuals, families and communities by identifying and supporting the most promising solutions to challenging health problems.

22 Jun 2011

Bureau of Labor Statistics: U.S. will need to add 580,000 nurses by 2018

The Bureau of Labor Statistics predicts the U.S. will need to add 580,000 nurses to the workforce by 2018. Moreover, these nurses will need higher skill levels than current nurses possess.

22 Jun 2011

Neuroscientists to discuss future of mental health treatments at NCDEU meeting

More than 1,000 of the world's leading neuroscientists gathered this week at the 51st Annual NCDEU Meeting to discuss the future of mental health treatments.

21 Jun 2011

Wayne State team receives $330,000 NSF grant to develop 3-D neural probe for tinnitus

A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.

21 Jun 2011

Rheonix, Mayo Clinic partner for genotyping test to assist warfarin sensitivity

Mayo Clinic today announced that it has reached an agreement with Rheonix, Inc. to collaborate on the performance of a genotyping test for warfarin sensitivity in clinical and research settings.

21 Jun 2011

Mayo Clinic announces collaboration on genotyping test for Warfarin sensitivity

Mayo Clinic today announced that it has reached an agreement with Rheonix, Inc. to collaborate on the performance of a genotyping test for warfarin sensitivity in clinical and research settings. The genotyping test will be available for all patients of Mayo Clinic and is the subject of ongoing research for improved anticoagulation therapy. Additionally, the test will be offered through Mayo Clinic’s reference laboratory, Mayo Medical Laboratories, to clients throughout the world.

20 Jun 2011

bioMD (BOD) announces new MD, new Chairman and Board

bioMD Limited (ASX:BOD), a company with assets in regenerative tissue engineering technologies today announced the appointment of a new Chairman, a new MD and other changes to its Board. This follows shareholder approval for the acquisition of Allied Medical Ltd., a company that specialises in the sales, distribution and commercialisation of medical technologies.

20 Jun 2011